|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Song QK, Wang XL, Zhou XN, Yang HB, Li YC,
Wu JP, Ren J and Lyerly HK: Breast cancer challenges and screening
in China: Lessons from current registry data and population
screening studies. Oncologist. 20:773–779. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gradishar WJ, Anderson BO, Abraham J, Aft
R, Agnese D, Allison KH, Blair SL, Burstein HJ, Dang C, Elias AD,
et al: Breast cancer, version 3.2020, NCCN clinical practice
guidelines in oncology. J Natl Compr Canc Netw. 18:452–478. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lissoni P, Sormani AL, Tancini G, Cattaneo
G, Archili C, Mandelli D, Crispino S, Paolorossi F and Barni S:
Postoperative hyperprolactinaemia and early recurrence rate in
breast cancer. Eur J Cancer. 26:953–956. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Murthy BL, Thomson CS, Dodwell D, Shenoy
H, Mikeljevic JS, Forman D and Horgan K: Postoperative wound
complications and systemic recurrence in breast cancer. Br J
Cancer. 97:1211–1217. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Macherey S, Mallmann P, Malter W, Doerr F,
Heldwein M, Wahlers T and Hekmat K: Lung metastasectomy for
pulmonary metastatic breast carcinoma. Geburtshilfe Frauenheilkd.
77:645–650. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ling CQ, Yue XQ and Ling C: Three
advantages of using traditional Chinese medicine to prevent and
treat tumor. J Integr Med. 12:331–335. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu X, Li M, Wang X, Dang Z, Yu L, Wang X,
Jiang Y and Yang Z: Effects of adjuvant traditional Chinese
medicine therapy on long-term survival in patients with
hepatocellular carcinoma. Phytomedicine. 62:1529302019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bing Z, Cheng Z, Shi D, Liu X, Tian J, Yao
X, Zhang J, Wang Y and Yang K: Investigate the mechanisms of
Chinese medicine Fuzhengkangai towards EGFR mutation-positive lung
adenocarcinomas by network pharmacology. BMC Complement Altern Med.
18:2932018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gezici S and Şekeroğlu N: Current
perspectives in the application of medicinal plants against cancer:
Novel therapeutic agents. Anticancer Agents Med Chem. 19:101–111.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Meng MB, Wen QL, Cui YL, She B and Zhang
RM: Meta-analysis: Traditional Chinese medicine for improving
immune response in patients with unresectable hepatocellular
carcinoma after transcatheter arterial chemoembolization. Explore
(NY). 7:37–43. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guo H, Liu JX, Xu L, Madebo T and Baak JP:
Traditional Chinese medicine herbal treatment may have a relevant
impact on the prognosis of patients with stage IV adenocarcinoma of
the lung treated with platinum-based chemotherapy or combined
targeted therapy and chemotherapy. Integr Cancer Ther. 10:127–137.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Deng LJ, Hu LP, Peng QL, Yang XL, Bai LL,
Yiu A, Li Y, Tian HY, Ye WC and Zhang DM: Hellebrigenin induces
cell cycle arrest and apoptosis in human hepatocellular carcinoma
HepG2 cells through inhibition of Akt. Chem Biol Interact.
219:184–194. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim I, Bae J and Kim BJ: Carthami flos
regulates gastrointestinal motility functions. Integr Med Res.
6:404–408. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
George VC, Dellaire G and Rupasinghe HPV:
Plant flavonoids in cancer chemoprevention: Role in genome
stability. J Nutr Biochem. 45:1–14. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang F, Li J, Zhu J, Wang D, Chen S and
Bai X: Hydroxysafflor yellow A inhibits angiogenesis of
hepatocellular carcinoma via blocking ERK/MAPK and NF-κB signaling
pathway in H22 tumor-bearing mice. Eur J Pharmacol. 754:105–114.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang J, Wang Y and Guo ML: Identification
and mapping of a novel hydroxysafflor yellow A (HSYA) biosynthetic
gene in Carthamus tinctorius. Biochem Genet. 49:410–415.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ao H, Feng W and Peng C: Hydroxysafflor
yellow A: A promising therapeutic agent for a broad spectrum of
diseases. Evid Based Complement Alternat Med. 2018:82592802018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qu C, Zhu W, Dong K, Pan Z, Chen Y, Chen
X, Liu X, Xu W, Lin H, Zheng Q and Li D: Inhibitory effect of
hydroxysafflor yellow B on the proliferation of human breast cancer
MCF-7 cells. Recent Pat Anticancer Drug Discov. 14:187–197. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yue S, Tang Y, Xu C, Li S, Zhu Y and Duan
JA: Two new quinochalcone C-glycosides from the florets of
Carthamus tinctorius. Int J Mol Sci. 15:16760–16771. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bouchalova K, Cizkova M, Cwiertka K,
Trojanec R and Hajduch M: Triple negative breast cancer-current
status and prospective targeted treatment based on HER1 (EGFR),
TOP2A and C-MYC gene assessment. Biomed Pap Med Fac Univ Palacky
Olomouc Czech Repub. 153:13–17. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ku JM, Kim SR, Hong SH, Choi HS, Seo HS,
Shin YC and Ko SG: Cucurbitacin D induces cell cycle arrest and
apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-
resistant human breast carcinoma (MCF7/ADR) cells. Mol Cell
Biochem. 409:33–43. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chou TC: Drug combination studies and
their synergy quantification using the Chou-Talalay method. Cancer
Res. 70:440–446. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ren B, Ye L, Gong J, Ren H, Ding Y, Chen
X, Liu X, Lu P, Wei F, Xu W, et al: Alteronol enhances the
anti-tumor activity and reduces the toxicity of high-dose
adriamycin in breast cancer. Front Pharmacol. 10:2852019.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Menna P, Paz OG, Chello M, Covino E,
Salvatorelli E and Minotti G: Anthracycline cardiotoxicity. Expert
Opin Drug Saf. 11 (Suppl 1):S21–S36. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Choi SH, Lee AY, Park CH, Shin YS and Cho
EJ: Protective effect of Carthamus tinctorius L. seed on
oxidative stress and cognitive impairment induced by chronic
alcohol consumption in mice. Food Sci Biotechnol. 27:1475–1484.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xi S, Zhang Q, Xie H, Liu L, Liu C, Gao X,
Zhang J, Wu L, Qian L and Deng X: Effects of hydroxy safflor yellow
A on blood vessel and mRNA expression with VEGF and bFGF of
transplantation tumor with gastric adenocarcinoma cell line BGC-823
in nude mice. Zhongguo Zhong Yao Za Zhi. 34:605–610. 2009.(In
Chinese). PubMed/NCBI
|
|
29
|
Zheng Z, Zhu W, Yang B, Chai R, Liu T, Li
F, Ren G, Ji S, Liu S and Li G: The co-treatment of metformin with
flavone synergistically induces apoptosis through inhibition of
PI3K/AKT pathway in breast cancer cells. Oncol Lett. 15:5952–5958.
2018.PubMed/NCBI
|
|
30
|
Hong M, Wang N, Tan HY, Tsao SW and Feng
Y: MicroRNAs and Chinese medicinal herbs: New possibilities in
cancer therapy. Cancers (Basel). 7:1643–1657. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Luo H, Vong CT, Chen H, Gao Y, Lyu P, Qiu
L, Zhao M, Liu Q, Cheng Z, Zou J, et al: Naturally occurring
anti-cancer compounds: Shining from Chinese herbal medicine. Chin
Med. 14:482019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim HP, Son KH, Chang HW and Kang SS:
Anti-inflammatory plant flavonoids and cellular action mechanisms.
J Pharmacol Sci. 96:229–245. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lin L and Zakeri ZF: Apoptosis in
development. Methods Mol Biol. 136:107–113. 2000.PubMed/NCBI
|
|
34
|
Weng D, Marty-Roix R, Ganesan S, Proulx
MK, Vladimer GI, Kaiser WJ, Mocarski ES, Pouliot K, Chan FK,
Kelliher MA, et al: Caspase-8 and RIP kinases regulate
bacteria-induced innate immune responses and cell death. Proc Natl
Acad Sci USA. 111:7391–7396. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pistritto G, Trisciuoglio D, Ceci C,
Garufi A and D'Orazi G: Apoptosis as anticancer mechanism: Function
and dysfunction of its modulators and targeted therapeutic
strategies. Aging (Albany NY). 8:603–619. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Elmore S: Apoptosis: A review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Brown R: The bcl-2 family of proteins. Br
Med Bull. 53:466–477. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Roset R, Ortet L and Gil-Gomez G: Role of
Bcl-2 family members on apoptosis: What we have learned from
knock-out mice. Front Biosci. 12:4722–4730. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zou J, Ardecky R, Pinkerton AB, Sergienko
E, Su Y, Stonich D, Curpan RF, Simons PC, Zhai D, Diaz P, et al:
Selective Bcl-2 inhibitor probes. Probe reports from the NIH
molecular libraries program Bethesda (MD): National Center for
Biotechnology Information (US); 2010, https://www.ncbi.nlm.nih.gov/books/NBK133437/October
31–2011
|
|
40
|
Burlacu A: Regulation of apoptosis by
Bcl-2 family proteins. J Cell Mol Med. 7:249–257. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Schindler CK, Shinoda S, Simon RP and
Henshall DC: Subcellular distribution of Bcl-2 family proteins and
14-3-3 within the hippocampus during seizure-induced neuronal death
in the rat. Neurosci Lett. 356:163–166. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tan KO, Fu NY, Sukumaran SK, Chan SL, Kang
JH, Poon KL, Chen BS and Yu VC: MAP-1 is a mitochondrial effector
of Bax. Proc Natl Acad Sci USA. 102:14623–14628. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bruckheimer EM, Cho SH, Sarkiss M,
Herrmann J and McDonnell TJ: The Bcl-2 gene family and apoptosis.
Adv Biochem Eng Biotechnol. 62:75–105. 1998.PubMed/NCBI
|
|
44
|
Tsukahara S, Yamamoto S, Tin-Tin-Win-Shwe,
Ahmed S, Kunugita N, Arashidani K and Fujimaki H: Inhalation of
low-level formaldehyde increases the Bcl-2/Bax expression ratio in
the hippocampus of immunologically sensitized mice.
Neuroimmunomodulation. 13:63–68. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Pan Y, Ye C, Tian Q, Yan S, Zeng X, Xiao
C, Wang L and Wang H: miR-145 suppresses the proliferation,
invasion and migration of NSCLC cells by regulating the BAX/BCL-2
ratio and the caspase-3 cascade. Oncol Lett. 15:4337–4343.
2018.PubMed/NCBI
|
|
46
|
Walensky LD: BCL-2 in the crosshairs:
Tipping the balance of life and death. Cell Death Differ.
13:1339–1350. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Hastak K, Gupta S, Ahmad N, Agarwal MK,
Agarwal ML and Mukhtar H: Role of p53 and NF-kappaB in
epigallocatechin-3-gallate-induced apoptosis of LNCaP cells.
Oncogene. 22:4851–4859. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lin HH, Chen JH, Huang CC and Wang CJ:
Apoptotic effect of 3,4-dihydroxybenzoic acid on human gastric
carcinoma cells involving JNK/p38 MAPK signaling activation. Int J
Cancer. 120:2306–2316. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kinnally KW and Antonsson B: A tale of two
mitochondrial channels, MAC and PTP, in apoptosis. Apoptosis.
12:857–868. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Skulachev VP: Role of uncoupled and
non-coupled oxidations in maintenance of safely low levels of
oxygen and its one-electron reductants. Q Rev Biophys. 29:169–202.
1996. View Article : Google Scholar : PubMed/NCBI
|
